Clinical trial
Comparison of the Beta Cell Mass During and Shortly After the Honeymoon Phase of Type 1 Diabetes Using Gallium-68-exendin PET
NCT03917238 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Beta Cell Mass During and Shortly After the Honeymoon Phase of Type 1 Diabetes Using Gallium-68-exendin PET
- Lead sponsor
- Radboud University Medical Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 11, 2019
- Completion date
- December 25, 2026
- Enrollment
- 14 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes mellitus